End-of-day quote
Korea S.E.
23:00:00 26/05/2024 BST
|
5-day change
|
1st Jan Change
|
807
KRW
|
+2.80%
|
|
-0.98%
|
+22.27%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
63,395
|
42,739
|
35,971
|
74,678
|
86,912
|
23,224
|
Enterprise Value (EV)
1 |
52,652
|
30,621
|
32,645
|
49,511
|
75,117
|
21,104
|
P/E ratio
|
-4.46
x
|
-5.94
x
|
-1.28
x
|
54.6
x
|
-8.52
x
|
-2.46
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2
x
|
2.04
x
|
1.37
x
|
2.7
x
|
4.06
x
|
1.67
x
|
EV / Revenue
|
1.66
x
|
1.46
x
|
1.24
x
|
1.79
x
|
3.51
x
|
1.52
x
|
EV / EBITDA
|
-21.5
x
|
-5.66
x
|
-1.73
x
|
17.8
x
|
-15.6
x
|
-3.35
x
|
EV / FCF
|
-9.02
x
|
-5.13
x
|
-1.89
x
|
-127
x
|
-13.9
x
|
-15.9
x
|
FCF Yield
|
-11.1%
|
-19.5%
|
-52.9%
|
-0.79%
|
-7.19%
|
-6.3%
|
Price to Book
|
1.8
x
|
1.13
x
|
3.08
x
|
2.46
x
|
3.16
x
|
1.29
x
|
Nbr of stocks (in thousands)
|
10,619
|
13,232
|
13,677
|
28,395
|
35,187
|
35,187
|
Reference price
2 |
5,970
|
3,230
|
2,630
|
2,630
|
2,470
|
660.0
|
Announcement Date
|
11/04/19
|
30/03/20
|
23/03/21
|
23/03/22
|
07/04/23
|
21/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
31,664
|
20,974
|
26,348
|
27,612
|
21,406
|
13,924
|
EBITDA
1 |
-2,451
|
-5,412
|
-18,858
|
2,783
|
-4,812
|
-6,299
|
EBIT
1 |
-4,752
|
-7,256
|
-20,630
|
1,907
|
-6,281
|
-6,840
|
Operating Margin
|
-15.01%
|
-34.6%
|
-78.3%
|
6.9%
|
-29.34%
|
-49.12%
|
Earnings before Tax (EBT)
1 |
-12,874
|
-8,131
|
-27,856
|
1,682
|
-10,096
|
-7,217
|
Net income
1 |
-13,059
|
-6,289
|
-27,852
|
1,213
|
-10,045
|
-9,438
|
Net margin
|
-41.24%
|
-29.99%
|
-105.71%
|
4.39%
|
-46.92%
|
-67.78%
|
EPS
2 |
-1,339
|
-543.7
|
-2,060
|
48.19
|
-290.0
|
-268.2
|
Free Cash Flow
1 |
-5,838
|
-5,972
|
-17,278
|
-390.9
|
-5,399
|
-1,330
|
FCF margin
|
-18.44%
|
-28.47%
|
-65.58%
|
-1.42%
|
-25.22%
|
-9.56%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/04/19
|
30/03/20
|
23/03/21
|
23/03/22
|
07/04/23
|
21/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
10,742
|
12,118
|
3,326
|
25,167
|
11,796
|
2,120
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-5,838
|
-5,972
|
-17,278
|
-391
|
-5,399
|
-1,330
|
ROE (net income / shareholders' equity)
|
-42.1%
|
-21.4%
|
-113%
|
6.86%
|
-31.1%
|
-31.7%
|
ROA (Net income/ Total Assets)
|
-5.52%
|
-8.31%
|
-36.8%
|
3.78%
|
-9.81%
|
-13.7%
|
Assets
1 |
236,781
|
75,699
|
75,606
|
32,064
|
102,395
|
69,086
|
Book Value Per Share
2 |
3,308
|
2,871
|
853.0
|
1,069
|
780.0
|
512.0
|
Cash Flow per Share
2 |
1,719
|
1,518
|
446.0
|
787.0
|
411.0
|
189.0
|
Capex
1 |
1,272
|
2,131
|
8,642
|
303
|
411
|
651
|
Capex / Sales
|
4.02%
|
10.16%
|
32.8%
|
1.1%
|
1.92%
|
4.67%
|
Announcement Date
|
11/04/19
|
30/03/20
|
23/03/21
|
23/03/22
|
07/04/23
|
21/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +22.27% | 20.87M | | +4.12% | 104B | | -9.10% | 61.03B | | +68.57% | 47.64B | | +17.86% | 39.24B | | +3.64% | 32.09B | | +13.29% | 20.39B | | +13.00% | 16.85B | | +11.62% | 14.28B | | +1.45% | 13.88B |
Other Commodity Chemicals
|